INTRODUCTION: A retrospective review of all patients with advanced oropharynx cancer from a single institution was performed. METHODS: Sixty-seven patients with stage III/IV oropharynx cancer were treated with definitive radiotherapy with or without concurrent chemotherapy from 1990 to 2004. Follow-up ranged from 6 to 91 months with a median of 32 months. RESULTS: Patients treated with concurrent chemotherapy had a statistically significant benefit for control above the clavicles, primary control, disease-free survival, and overall survival but no difference in distant control at 3 years. Cox proportional regression model demonstrated the use of concurrent chemotherapy to be the only independent variable that reached significance for control above the clavicles, primary control, and overall survival. Complete dysphagia for solids and/or gastrostomy tube dependence was observed in more patients who were treated with chemoradiation than those treated with radiation alone; 18% and 0%, respectively (P = 0.04). CONCLUSIONS: Concurrent chemotherapy decreases the recurrence at the primary site and above the clavicles. The most notable difference in sequelae between the 2 groups was the increase in swallowing dysfunction with concurrent chemotherapy.
INTRODUCTION: A retrospective review of all patients with advanced oropharynx cancer from a single institution was performed. METHODS: Sixty-seven patients with stage III/IV oropharynx cancer were treated with definitive radiotherapy with or without concurrent chemotherapy from 1990 to 2004. Follow-up ranged from 6 to 91 months with a median of 32 months. RESULTS:Patients treated with concurrent chemotherapy had a statistically significant benefit for control above the clavicles, primary control, disease-free survival, and overall survival but no difference in distant control at 3 years. Cox proportional regression model demonstrated the use of concurrent chemotherapy to be the only independent variable that reached significance for control above the clavicles, primary control, and overall survival. Complete dysphagia for solids and/or gastrostomy tube dependence was observed in more patients who were treated with chemoradiation than those treated with radiation alone; 18% and 0%, respectively (P = 0.04). CONCLUSIONS: Concurrent chemotherapy decreases the recurrence at the primary site and above the clavicles. The most notable difference in sequelae between the 2 groups was the increase in swallowing dysfunction with concurrent chemotherapy.
Authors: G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand Journal: J Natl Cancer Inst Date: 1999-12-15 Impact factor: 13.506
Authors: Arlene A Forastiere; Helmuth Goepfert; Moshe Maor; Thomas F Pajak; Randal Weber; William Morrison; Bonnie Glisson; Andy Trotti; John A Ridge; Clifford Chao; Glen Peters; Ding-Jen Lee; Andrea Leaf; John Ensley; Jay Cooper Journal: N Engl J Med Date: 2003-11-27 Impact factor: 91.245
Authors: William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; Robert S Malyapa; John W Werning; Christopher D Lansford; Douglas B Villaret Journal: Am J Clin Oncol Date: 2006-06 Impact factor: 2.339
Authors: René-Jean Bensadoun; Karen Bénézery; Olivier Dassonville; Nicolas Magné; Gilles Poissonnet; Alain Ramaïoli; Claire Lemanski; Sylvain Bourdin; Jacques Tortochaux; Frédéric Peyrade; Pierre-Yves Marcy; Emmanuel Chamorey; Jacques Vallicioni; Hang Seng; Claude Alzieu; Bernard Géry; Pierre Chauvel; Maurice Schneider; José Santini; François Demard; Gilles Calais Journal: Int J Radiat Oncol Biol Phys Date: 2006-01-10 Impact factor: 7.038
Authors: William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; John W Werning; Douglas B Villaret Journal: Am J Clin Oncol Date: 2006-02 Impact factor: 2.339
Authors: Jeri A Logemann; Alfred W Rademaker; Barbara Roa Pauloski; Cathy L Lazarus; Bharat B Mittal; Bruce Brockstein; Ellen MacCracken; Daniel J Haraf; Everett E Vokes; Lisa A Newman; Dachao Liu Journal: Head Neck Date: 2006-01 Impact factor: 3.147
Authors: Avraham Eisbruch; Teresa Lyden; Carol R Bradford; Laura A Dawson; Marc J Haxer; Amy E Miller; Theodoros N Teknos; Douglas B Chepeha; Norman D Hogikyan; Jeffrey E Terrell; Gregory T Wolf Journal: Int J Radiat Oncol Biol Phys Date: 2002-05-01 Impact factor: 7.038
Authors: A S Garden; J Harris; E E Vokes; A A Forastiere; J A Ridge; C Jones; E M Horwitz; B S Glisson; L Nabell; J S Cooper; W Demas; E Gore Journal: J Clin Oncol Date: 2004-07-15 Impact factor: 44.544
Authors: William M Mendenhall; Christopher G Morris; Robert J Amdur; Russell W Hinerman; Anthony A Mancuso Journal: Head Neck Date: 2003-07 Impact factor: 3.147
Authors: Jason T Rich; Simon Milov; James S Lewis; Wade L Thorstad; Douglas R Adkins; Bruce H Haughey Journal: Laryngoscope Date: 2009-09 Impact factor: 3.325
Authors: Alexander N Goel; Sophia Sangar; Laith Mukdad; Chase M Heaton; William R Ryan; Marilene B Wang; Jennifer L Long; Maie A St John Journal: Head Neck Date: 2019-05-20 Impact factor: 3.147
Authors: Martin Canis; Alexios Martin; Martina Kron; Alexandra Konstantinou; Friedrich Ihler; Hendrik A Wolff; Christoph Matthias; Wolfgang Steiner Journal: Eur Arch Otorhinolaryngol Date: 2012-12-29 Impact factor: 2.503